Beijing’s Changping District and State-owned Capital Firm Launch RMB 20 Billion Healthcare Fund
The Changping district of Beijing municipality has reached an agreement with Beijing State-owned Capital Operation...
Deals
Gilead Strikes Deal with Xilio Therapeutics for Tumor-Activated IL-12 Candidate
Gilead Sciences (NASDAQ: GILD) has announced an in-licensing agreement with fellow US biotechnology company Xilio...
BeiGene and GenFleet Join Forces for DLBCL Trial Combining Brukinsa and GFH009
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a China-based biotechnology company, has entered into...
Shanghai Medicilon Forms Strategic Partnerships with Binhui Biopharmaceutical and Innoforce Pharmaceuticals
Shanghai Medicilon Biomedical Co., Ltd (SHA: 688202), a prominent Chinese biotech firm, has entered into...
BeiGene Terminates Partnership with Shoreline Therapeutics for NK Cell Therapies
A close examination of BeiGene’s (NASDAQ: BGNE; HKG: 6160; SHA: 688235) recent annual report has...
Recbio and Rongsheng Biotech Join Forces to Develop New Adjuvant Vaccine Technologies
Jiangsu Recbio Technology Co., Ltd (HKG: 2179) and Shanghai Rongsheng Biotech Co., Ltd have announced...
Merck Expands Global Footprint with Largest M Lab Collaboration Center in Shanghai
Merck KGaA (ETR: MRK), a leading German technology company, has announced the completion of the...
Kangtai Biological Partners with AstraZeneca and Beijing Daxing District to Boost Vaccine Market Presence
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a prominent biopharmaceutical company based in China,...
AbbVie Acquires Landos Biopharma to Boost Autoimmune Disease Pipeline
AbbVie (NYSE: ABBV) has announced its acquisition of Landos Biopharma (NASDAQ: LABP), a biopharmaceutical company...
Shanghai Pharmaceuticals, SHC, and CEMCS CAS Renew Partnership to Incubate Pharmaceutical Innovations
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, SHA: 601607; HKG: 2607), a leading pharmaceutical company in...
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Deal Amid Biotech Pressures
U.S.-based biotech Nuvation Bio Inc. (NYSE: NUVB) has announced a definitive agreement to acquire China-based...
Fosun Health and Adventist Medical Center Partner to Enhance GBA Medical Services
China-based Fosun Health Consumption Industry Group has entered into a strategic partnership with Hong Kong’s...
Biocytogen and ABL Bio Forge Partnership to Advance Bispecific ADC Development
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has entered into a partnership with South...
HitGen Secures Strategic Partnerships to Enhance Drug Discovery for Startups
China-based HitGen Inc. (SHA: 688222) has announced strategic partnerships with LabCentral, a prominent life science...
Novo Nordisk Acquires Cardior for €1.025 Billion to Strengthen Cardiovascular Portfolio
Denmark-based Novo Nordisk (CPH: NOVO-B) has announced a significant agreement to acquire Germany’s Cardior, a...
Novo Nordisk Expands Benzalkonium Chloride Distribution with Actylis Across Europe
Denmark’s Novo Nordisk (CPH: NOVO-B), through its Pharmatech division, announced a partnership this week with...
OBiO Technology Partners with Saierxin Bio to Support Treg Cell Therapy Development
OBiO Technology (Shanghai) Co., Ltd (SHA: 688238), a Chinese Contract Research Organization (CRO) specializing in...
Zhejiang Dian Diagnostics Partners with Haihe Laboratory to Advance Hematology Diagnostics
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a company based in China, has entered into...
Golden Leaf Med Tec Secures Series D Funding to Advance Hypertension and Diabetes Treatments
Shanghai Golden Leaf Med Tec Co., Ltd, a specialist in interventional treatments based in China,...
Joincare Pharmaceuticals Secures Rights to Bayer’s Respiratory Drug in China
Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380), a Chinese pharmaceutical company, has announced a...